2-{3-fluoro-4'-hydroxy-5-[(2-oxocyclopentyl)methyl]biphenyl-2-yl}propanoic acid | 1377934-91-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-{3-fluoro-4'-hydroxy-5-[(2-oxocyclopentyl)methyl]biphenyl-2-yl}propanoic acid
• 英文别名: 2-[2-Fluoro-6-(4-hydroxyphenyl)-4-[(2-oxocyclopentyl)methyl]phenyl]propanoic acid
• CAS: 1377934-91-2
• 化学式: C₂₁H₂₁FO₄
• 分子量: 356.394
• InChiKey: RLOAKDJOSNIQNV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  26
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  2-[2-bromo-6-fluoro-4-{(2-oxocyclopentyl)methyl}phenyl]propanoic acid 在 4-二甲氨基吡啶 、 trans-bromo(N-succinimidyl)-bis(triphenylphosphine)palladium(II) 、 水 、 sodium carbonate 、 potassium hydroxide 作用下， 以 四氢呋喃 、 乙醇 、 水 、 1,2-二氯乙烷 为溶剂， 反应 3.0h， 生成 2-{3-fluoro-4'-hydroxy-5-[(2-oxocyclopentyl)methyl]biphenyl-2-yl}propanoic acid
  参考文献：
  名称：

  Synthesis and Biological Evaluation of Derivatives of 2-{2-Fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic Acid: Nonsteroidal Anti-Inflammatory Drugs with Low Gastric Ulcerogenic Activity

  摘要：

  We previously reported that 2-fluoroloxoprofen has lower gastric ulcerogenic activity than loxoprofen, a nonsteroidal anti-inflammatory drug (NSAID) without selectivity for COX-2. We synthesized derivatives of 2-fluoroloxoprofen and studied their properties. Compared to 2-fluoroloxoprofen, one derivative, 1 la, exhibited higher anti-inflammatory activity and an equivalent ulcerogenic effect. These results suggest that 11a could be therapeutically beneficial for use as an NSAID.

  DOI：

  10.1021/jm300049g

文献信息

• 2-FLUOROPHENYL PROPIONIC ACID DERIVATIVES
  申请人：LTT BIO-PHARMA CO., LTD.

  公开号：US20140330026A1

  公开（公告）日：2014-11-06

  Provided are novel 2-fluorophenyl propionic acid derivatives which have excellent anti-inflammatory/analgesic effects while avoiding side effects such as gastrointestinal disorders, namely 2-fluorophenyl propionic acid derivatives represented by the formula (I) below or pharmaceutically acceptable salts thereof, [wherein, R 1 represents a hydrogen atom, a halogen atom, or a substituted or unsubstituted phenyl group, X represents —CH 2 —, —NH—, —O—, or —S—, and Y specifically represents group (II) (wherein, Z 1 represents —CO—, —CH(OH)—, or —CH 2 —, and n represents an integer of 1 or 2.)]

  提供了具有出色抗炎/镇痛效果且避免胃肠道疾病等副作用的新型2-氟苯丙酸衍生物，即由下面的式(I)所代表的2-氟苯丙酸衍生物或其药学上可接受的盐，其中，R1代表氢原子、卤原子或取代或未取代的苯基，X代表—CH2—、—NH—、—O—或—S—，Y具体表示群（II）（其中，Z1代表—CO—、—CH(OH)—或—CH2—，n代表1或2的整数）。
• US9221786B2
  申请人：——

  公开号：US9221786B2

  公开（公告）日：2015-12-29
• Synthesis and Biological Evaluation of Derivatives of 2-{2-Fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic Acid: Nonsteroidal Anti-Inflammatory Drugs with Low Gastric Ulcerogenic Activity
  作者：Naoki Yamakawa、Shintaro Suemasu、Yoshinari Okamoto、Ken-ichiro Tanaka、Tomoaki Ishihara、Teita Asano、Keishi Miyata、Masami Otsuka、Tohru Mizushima

  DOI：10.1021/jm300049g

  日期：2012.6.14

  We previously reported that 2-fluoroloxoprofen has lower gastric ulcerogenic activity than loxoprofen, a nonsteroidal anti-inflammatory drug (NSAID) without selectivity for COX-2. We synthesized derivatives of 2-fluoroloxoprofen and studied their properties. Compared to 2-fluoroloxoprofen, one derivative, 1 la, exhibited higher anti-inflammatory activity and an equivalent ulcerogenic effect. These results suggest that 11a could be therapeutically beneficial for use as an NSAID.